164 related articles for article (PubMed ID: 20143430)
1. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis.
Liggett T; Melnikov A; Yi QL; Replogle C; Brand R; Kaul K; Talamonti M; Abrams RA; Levenson V
Cancer; 2010 Apr; 116(7):1674-80. PubMed ID: 20143430
[TBL] [Abstract][Full Text] [Related]
2. Methylation profile of circulating plasma DNA in patients with pancreatic cancer.
Melnikov AA; Scholtens D; Talamonti MS; Bentrem DJ; Levenson VV
J Surg Oncol; 2009 Feb; 99(2):119-22. PubMed ID: 19065635
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in diagnosis of pancreatic neoplasms.
Watanabe H; Okada G; Ohtsubo K; Yao F; Jiang PH; Mouri H; Wakabayashi T; Sawabu N
Pancreas; 2006 May; 32(4):382-9. PubMed ID: 16670620
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
[TBL] [Abstract][Full Text] [Related]
5. The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer.
Park JK; Ryu JK; Yoon WJ; Lee SH; Lee GY; Jeong KS; Kim YT; Yoon YB
Pancreas; 2012 Jan; 41(1):95-101. PubMed ID: 21778928
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
[TBL] [Abstract][Full Text] [Related]
7. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
Novotný I; Dítĕ P; Dastych M; Záková A; Trna J; Novotná H; Nechutová H
Hepatogastroenterology; 2008; 55(85):1475-7. PubMed ID: 18795715
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis.
Chang MC; Chang YT; Su TC; Yang WS; Chen CL; Tien YW; Liang PC; Wei SC; Wong JM
Pancreas; 2007 Jul; 35(1):16-21. PubMed ID: 17575540
[TBL] [Abstract][Full Text] [Related]
9. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
[TBL] [Abstract][Full Text] [Related]
10. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite analysis in serum DNA as a diagnostic tool for distinction of patients with unknown pancreatic masses.
Wachowiak R; Kaifi J; Schwarzenbach H; Yekebas E; Merkert P; Schurr P; Hansen B; Reichelt U; Strate T; Pantel K; Izbicki JR
Diagn Mol Pathol; 2007 Sep; 16(3):174-8. PubMed ID: 17721326
[TBL] [Abstract][Full Text] [Related]
12. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.
Koopmann J; Rosenzweig CN; Zhang Z; Canto MI; Brown DA; Hunter M; Yeo C; Chan DW; Breit SN; Goggins M
Clin Cancer Res; 2006 Jan; 12(2):442-6. PubMed ID: 16428484
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
14. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis.
Varadarajulu S; Tamhane A; Eloubeidi MA
Gastrointest Endosc; 2005 Nov; 62(5):728-36; quiz 751, 753. PubMed ID: 16246688
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.
Wang L; Friess H; Zhu Z; Graber H; Zimmermann A; Korc M; Reubi JC; Büchler MW
Clin Cancer Res; 2000 Feb; 6(2):566-71. PubMed ID: 10690540
[TBL] [Abstract][Full Text] [Related]
16. p16(INK4a) alterations in chronic pancreatitis-indicator for high-risk lesions for pancreatic cancer.
Gerdes B; Ramaswamy A; Kersting M; Ernst M; Lang S; Schuermann M; Wild A; Bartsch DK
Surgery; 2001 Apr; 129(4):490-7. PubMed ID: 11283541
[TBL] [Abstract][Full Text] [Related]
17. Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma.
Liao WC; Wu MS; Wang HP; Tien YW; Lin JT
Pancreas; 2009 May; 38(4):422-6. PubMed ID: 19214136
[TBL] [Abstract][Full Text] [Related]
18. Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer.
Kumari A; Srinivasan R; Vasishta RK; Wig JD
Ann Surg Oncol; 2009 Apr; 16(4):1051-9. PubMed ID: 19194757
[TBL] [Abstract][Full Text] [Related]
19. Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland.
Lempinen M; Paju A; Kemppainen E; Smura T; Kylänpää ML; Nevanlinna H; Stenman J; Stenman UH
Scand J Gastroenterol; 2005 Feb; 40(2):225-30. PubMed ID: 15764155
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum biomarker signatures associated with pancreatic cancer.
Wingren C; Sandström A; Segersvärd R; Carlsson A; Andersson R; Löhr M; Borrebaeck CA
Cancer Res; 2012 May; 72(10):2481-90. PubMed ID: 22589272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
